Matinas BioPharma Holdings, Inc. (MTNB)
Largest Insider Buys in Sector
MTNB Stock Price History Chart
MTNB Stock Performance
About Matinas BioPharma Holdings, Inc.
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is LYPDISO, a prescription-only omega-3 free fatty acid-based composition intended for the treatment of cardiovascular and metabolic conditions. The company also offers MAT2203, an oral formulation of amphotericin B that is in Phase II clinical trials for the prevention of invasive fungal infections due to immunosuppressive therapy in patients. In addition, it provides MAT2501, an orally administered formulation of the broad-spectrum aminoglycoside antibiotic amikacin that has completed Phase I clinical trials to treat various types of multidrug-resistant bacteria, including non-tuberculous mycobacterium infections, as well as various multidrug-resistant gram negative and intracellular bacterial infections. Matinas BioPharma Holdings, Inc. has a research collaboration with the National Institute of Allergy and Infectious Diseases for the development of Gilead's antiviral remdesivir; and a feasibility collaboration with Genentech, Inc. for the development of oral formulations. The company was incorporated in 2013 and is based in Bedminster, New Jersey.
Insider Activity of Matinas BioPharma Holdings, Inc.
Over the last 12 months, insiders at Matinas BioPharma Holdings, Inc. have bought $0 and sold $0 worth of Matinas BioPharma Holdings, Inc. stock.
On average, over the past 5 years, insiders at Matinas BioPharma Holdings, Inc. have bought $265,929 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 20,000 shares for transaction amount of $16,600 was made by STERN ADAM K (director) on 2020‑08‑21.
List of Insider Buy and Sell Transactions, Matinas BioPharma Holdings, Inc.
| 2020-08-21 | STERN ADAM K | director | 20,000 0.01% | $0.83 | $16,600 | |||
| 2020-05-14 | LEPORE PATRICK G | director | 100,000 0.0504% | $0.73 | $73,050 | |||
| 2020-03-17 | Jabbour Jerome D | President and CEO | 10,000 0.0051% | $0.65 | $6,500 | |||
| 2020-03-17 | STERN ADAM K | director | 10,000 0.0051% | $0.65 | $6,500 | |||
| 2019-11-25 | Kucinski Keith A | Chief Financial Officer | 116,000 0.0387% | $0.61 | $71,160 | |||
| 2019-11-22 | Kucinski Keith A | Chief Financial Officer | 73,000 0.0234% | $0.60 | $43,807 | |||
| 2019-11-15 | LEPORE PATRICK G | director | 200,000 0.0623% | $0.53 | $105,530 | |||
| 2019-08-20 | Ende Eric J | director | 40,000 0.0126% | $0.33 | $13,200 | |||
| 2019-08-19 | STERN ADAM K | director | 20,800 0.0135% | $0.70 | $14,535 | |||
| 2019-08-19 | Jabbour Jerome D | President and CEO | 29,300 0.0093% | $0.34 | $9,975 | |||
| 2019-08-19 | Ende Eric J | director | 40,000 0.0254% | $0.68 | $27,300 | |||
| 2019-08-16 | LEPORE PATRICK G | director | 200,000 0.1309% | $0.72 | $143,700 | |||
| 2019-06-14 | STERN ADAM K | director | 30,000 0.021% | $0.80 | $24,000 | |||
| 2019-06-12 | STERN ADAM K | director | 40,000 0.0282% | $0.80 | $31,996 | |||
| 2019-06-12 | Jabbour Jerome D | President and CEO | 24,974 0.0176% | $0.80 | $19,959 | |||
| 2019-06-10 | STERN ADAM K | director | 30,000 0.0206% | $0.82 | $24,600 | |||
| 2019-06-07 | STERN ADAM K | director | 40,000 0.0293% | $0.89 | $35,600 | |||
| 2019-05-31 | STERN ADAM K | director | 160,000 0.1095% | $0.94 | $150,400 | |||
| 2019-05-16 | STERN ADAM K | director | 300,000 0.2128% | $0.95 | $285,000 | |||
| 2019-05-16 | CONRAD HERBERT J | director | 50,000 0.036% | $0.96 | $48,230 |
Institutional Investor Ownership
| The Vanguard Group | $2.53M | 3.72 | 9.32M | 0% | +$0 | <0.0001 | |
| Sargent Investment Group Llc | $978,446.00 | 1.44 | 3.61M | -5.43% | -$56,232.53 | 0.23 | |
| BlackRock | $672,730.00 | 0.99 | 2.48M | -0.74% | -$5,043.58 | <0.0001 | |
| Geode Capital Management | $578,856.00 | 0.85 | 2.14M | +35.45% | +$151,512.34 | <0.0001 | |
| Arkadios Wealth Advisors | $440,104.00 | 0.65 | 1.62M | 0% | +$0 | 0.04 | |
| Neville, Rodie and Shaw, Inc. | $314,000.00 | 0.46 | 1.16M | 0% | +$0 | 0.03 | |
| Jtc Employer Solutions Trustee Ltd | $222,000.00 | 0.31 | 775,000 | 0% | +$0 | 0.01 | |
| State Street | $178,825.00 | 0.26 | 659,871 | -7.38% | -$14,254.60 | <0.0001 | |
| LINSCO PRIVATE LEDGER CORP | $165,941.00 | 0.24 | 612,328 | -0.2% | -$325.20 | <0.0001 | |
| Northern Trust | $116,707.00 | 0.17 | 430,654 | +18.87% | +$18,528.50 | <0.0001 | |
| Renaissance Technologies | $112,000.00 | 0.17 | 414,037 | +11.41% | +$11,469.51 | <0.0001 | |
| Main Street Financial Solutions Llc | $108,624.00 | 0.16 | 400,826 | 0% | +$0 | 0.01 | |
| Staley Capital Advisers, Inc. | $108,400.00 | 0.16 | 400,000 | 0% | +$0 | 0.01 | |
| Private Advisor Group | $94,045.00 | 0.14 | 347,030 | +2.88% | +$2,628.70 | <0.01 | |
| Bank of America | $35,193.00 | 0.05 | 129,865 | +47,644.48% | +$35,119.29 | <0.0001 | |
| Wealth Enhancement Advisory Services LLC | $32,348.00 | 0.05 | 119,367 | 0% | +$0 | <0.0001 | |
| Wells Fargo | $28,935.00 | 0.04 | 106,774 | -53.93% | -$33,866.80 | <0.0001 | |
| Modera Wealth Management | $25,610.00 | 0.04 | 94,500 | 0% | +$0 | <0.0001 | |
| Hyman Charles D | $22,000.00 | 0.03 | 79,800 | 0% | +$0 | <0.01 | |
| Bleakley Financial Group Llc | $16,264.00 | 0.02 | 60,016 | 0% | +$0 | <0.0001 | |
| Simplicity Wealth Llc | $16,264.00 | 0.02 | 60,016 | New | +$16,264.00 | <0.0001 | |
| Morgan Stanley | $12,874.00 | 0.02 | 47,507 | +72.75% | +$5,421.46 | <0.0001 | |
| JPMorgan Chase | $12,331.00 | 0.02 | 45,501 | +0.24% | +$29.00 | <0.0001 | |
| UBS | $12,166.00 | 0.02 | 44,893 | New | +$12,166.00 | <0.0001 | |
| Tower Research Capital | $7,913.00 | 0.01 | 29,199 | -26.84% | -$2,903.52 | <0.0001 | |
| Dynamic Advisor Solutions Llc | $7,477.00 | 0.01 | 27,590 | 0% | +$0 | <0.0001 | |
| Bridgeway Capital Management | $7,182.00 | 0.01 | 26,500 | -72.54% | -$18,971.32 | <0.0001 | |
| BNY Mellon | $5,461.00 | 0.01 | 20,151 | -77.65% | -$18,970.27 | <0.0001 | |
| Rossmore Private Capital | $4,742.00 | 0.01 | 17,500 | 0% | +$0 | <0.01 | |
| Clarus Group Inc | $3,252.00 | 0.01 | 12,000 | 0% | +$0 | <0.01 | |
| Advisor Group Holdings Inc | $2,700.00 | <0.01 | 10,000 | 0% | +$0 | <0.0001 | |
| CRA Financial Services LLC | $2,710.00 | <0.01 | 10,000 | 0% | +$0 | <0.01 | |
| J W Cole Advisors Inc | $2,914.00 | <0.01 | 10,752 | 0% | +$0 | <0.0001 | |
| Royal Bank of Canada | $3,000.00 | <0.01 | 10,431 | +44.43% | +$922.92 | <0.0001 | |
| Fidelity Investments | $1,355.00 | <0.01 | 5,000 | +42.86% | +$406.50 | <0.0001 | |
| Steward Partners Investment Advisory LLC | $824.00 | <0.01 | 3,040 | 0% | +$0 | <0.0001 | |
| EverSource Wealth Advisors | $649.00 | <0.01 | 3,000 | 0% | +$0 | <0.0001 |